Tag Archives: Nina Groven

Research: Kynurenine metabolites & ratios differ between CFS, FM, & healthy controls

Posted on 07/21/2021 by wames

Kynurenine metabolites and ratios differ between Chronic Fatigue Syndrome, Fibromyalgia, and healthy controls, by Nina Groven, Solveig Klæbo Reitan, Egil Andreas Fors, Ismail Cuneyt Guzey in Psychoneuroendocrinology 2021 May 27;131:105287 [doi: 10.1016/j.psyneuen.2021.105287]   Highlights: Quinolinic acid differs between CFS and … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Research: Kynurenine metabolites & ratios differ between CFS, FM, & healthy controls

MCP-1 is increased in patients with CFS & FM, whilst several other immune markers are significantly lower than healthy controls

Posted on 04/20/2020 by wames

MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls, by Nina Groven, Egil Andreas Fors, Astrid Kamilla Stunes, Solveig Klæbo Reitan in Brain, Behavior, & Immunity – Health Vol … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off on MCP-1 is increased in patients with CFS & FM, whilst several other immune markers are significantly lower than healthy controls

Patients with FM & CFS show increased hsCRP compared to healthy controls

Posted on 06/24/2019 by wames

Patients with Fibromyalgia and Chronic Fatigue Syndrome show increased hsCRP compared to healthy controls, by Nina Groven, Egil A Fors, Solveig KlæboReitan, in Brain, Behavior, and Immunity [Available online 7 June 2019] https://doi.org/10.1016/j.bbi.2019.06.010 Highlights CFS/ME and Fibromyalgia share common features of … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Patients with FM & CFS show increased hsCRP compared to healthy controls